Osteogenesis imperfecta and congenital dislocation of the hip.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to L H Williams.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A child with triose phosphate isomerase deficiency was born to nonconsanguineous parents, and died at 13 months of age. The parents were both found to be heterozygous for this enzyme deficiency. At a subsequent pregnancy, analysis of fetal red blood cells obtained by cordocentesis at 19 weeks' gestation enabled prenatal diagnosis of the heterozygous state. This technique may allow diagnosis of other red-cell enzymopathies during the second trimester.
Long-term bone marrow culture was used to examine the hematopoietic toxicity of the chemotherapeutic agent methotrexate. A dose-related suppression in myelopoiesis was seen when cultures were treated with 10(-3), 10(-4), or 10(-5) M methotrexate followed by folinic acid rescue. Differential counts revealed an initial decrease of postmitotic myeloid cells followed by mitotic precursors and myeloid colony-forming units (CFU-C). Myelopoiesis had disappeared by 7-10 days when 10(-3) M methotrexate was studied, by day 21 with 10(-4) M methotrexate, and by day 28 with 10(-5) M methotrexate. Although 10(-3) M methotrexate caused a predictable suppression in myelopoiesis, the effect of 10(-5) M methotrexate was more variable. In some studies this dose caused significant suppression of myelopoiesis, whereas in others less suppression occurred. This provides some evidence for varying host susceptibility to drug. Microenvironmental (adherent layer) cells were also affected by methotrexate. An increase in proliferation of these cells occurred in proportion to the dose of methotrexate added to culture. Methotrexate did not affect the ability of the adherent cells to produce colony-stimulating activity (CSA), but high doses did prevent the layer's ability to support the proliferation of adherent cell-free marrow. These results indicate that long-term bone marrow culture can be used to successfully predict and define chemotherapeutic host toxicity.
The effect of age on hematopoiesis was studied in young (six-month) and old (24-month) C57BL/6 mice. In addition, studies were performed on very old (42-month) mice, housed either singly or in groups of five animals per cage. Although a reduction in hematocrit was found in the older mice, red cell mass was normal in both old and very old single-caged mice. A detailed evaluation of erythropoiesis that included plasma- and erythron-iron turnover (PIT and EIT), red cell survival, and quantitation of the marrow erythroid progenitor and differentiated cells demonstrated no age-related change in single-caged animals. Similarly, quantitation of marrow myeloid precursors was identical in these groups. These results indicate that no age-related change in basal hematopoiesis can be demonstrated even in animals approaching maximal life expectancy. When very old mice were routinely housed in groups of five per cage, however, a decrease in hematocrit was found which was accompanied by significant alterations in hematopoiesis, including reductions in total differentiated erythroid cells, erythroid burst-forming units (BFU-E), erythroid colony-forming units (CFU-E), and colony-forming-unit culture (CFU-C) levels. It is likely that in very old animals, group housing constitutes a sufficient stress to compromise hematopoiesis. These findings indicate that basal hematopoiesis is unaltered by aging, although the bone marrow's reserve capacity is markedly compromised.
A child with Down's syndrome and long standing severe hypothyroidism had a massive pericardial effusion without cardiac tamponade. The effusion completely resolved with medical treatment without pericardiocentesis.
A girl aged 1 year died of acute haemorrhagic pancreatitis while taking sodium valproate. Necropsy showed widespread vascular disease that may have contributed to the onset of pancreatitis. Previous reports of pancreatitis in children receiving valproic acid are reviewed and although the association is rare, a causal relation between pancreatitis and valproic acid seems to have been established.
The use of amniotic fluid amylase (AF amylase) has been proposed as a screening test to determine fetal maturity. We reviewed data from 944 amniotic fluid samples analyzed by our laboratory for amylase and lecithin sphingomyelin (L/S) ratio between 1975 and 1980. AF amylase shows poor overall correlation with L/S ratios (r = 0.256). Retrospective analysis of AF amylase as a screen to determine the need for L/S ratios showed an overall sensitivity of 57%, and an overall specificity of 86% for AF amylase. Three groups were studied: a low amylase group (amylase less than 200 U/L), a middle group (amylase 200-300 U/L), and a high amylase group (amylase greater than 300 U/L). Only 55% of the low amylase group had an immature L/S ratio. The high amylase group had the best correlation between AF amylase and L/S ratio, but 13% of these samples had an immature or borderline L/S ratio. We conclude that AF amylase cannot be used as a screening test to determine the need to perform L/S ratios.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.